Back
Biogen Vs. Bristol-Myers Squibb Industry Stock Comparison
Sell
50
BIIB
Biogen
Last Price:
215.50
Seasonality Move:
8.62%
Sell
33
BMY
Bristol-Myers Squibb
Last Price:
44.60
Seasonality Move:
2.91%
Sell
50
Biogen (BIIB)
is a Sell
Is Biogen a Buy, Sell or Hold?
- The current Biogen [BIIB] share price is $215.50. The Score for BIIB is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- BIIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Bristol-Myers Squibb (BMY)
is a Sell
Is Bristol-Myers Squibb a Buy, Sell or Hold?
- The current Bristol-Myers Squibb [BMY] share price is $44.64. The Score for BMY is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- BMY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BIIB Stock Price Chart
BMY Stock Price Chart
What is Bristol-Myers Squibb's stock price today?
-
The Bristol-Myers Squibb share price today is $44.64
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMY is experiencing selling pressure, which indicates risk of future bearish movement.
BIIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.68 | Sell |
| Relative Strength Index (14 RSI): | 61.95 | Buy |
| Chaikin Money Flow: | 716645 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (195.91 - 212.01) | Buy |
| Bollinger Bands (100): | (209.84 - 250.68) | Sell |
BMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.54 | Sell |
| Relative Strength Index (14 RSI): | 23.98 | Sell |
| Chaikin Money Flow: | -12167218 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (47.22 - 52.48) | Sell |
| Bollinger Bands (100): | (48.79 - 52.43) | Sell |
BIIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 200.14 | Buy |
| 20-day SMA: | 201.16 | Buy |
| 50-day SMA: | 212.56 | Buy |
| 200-day SMA: | 243 | Sell |
| 8-day EMA: | 203.83 | Buy |
| 20-day EMA: | 203.78 | Buy |
| 50-day EMA: | 212.74 | Buy |
| 200-day EMA: | 238.46 | Sell |
BMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.3 | Sell |
| 20-day SMA: | 49.05 | Sell |
| 50-day SMA: | 50.84 | Sell |
| 200-day SMA: | 54.02 | Sell |
| 8-day EMA: | 46.73 | Sell |
| 20-day EMA: | 48.52 | Sell |
| 50-day EMA: | 49.98 | Sell |
| 200-day EMA: | 54.31 | Sell |
Biogen Earnings Growth & BIIB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, an increase next quarter of $0.04 per share, an increase this year of $0.64 per share, and an increase next year of $1.73 per share.
Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, an increase next quarter of $0.23 per share, a decrease this year of $6.88 per share, and an increase next year of $6.46 per share.
Biogen Technical Analysis
| Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bristol-Myers Squibb Technical Analysis
| Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||